BYDUREON

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug BYDUREON contains one active pharmaceutical ingredient (API):

1 Exenatide UNII 9P1872D4OL - EXENATIDE

Exenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that exhibits several antihyperglycaemic actions of glucagon-like peptide-1 (GLP-1). The amino acid sequence of exenatide partially overlaps that of human GLP-1. Exenatide has been shown to bind to and activate the known human GLP-1 receptor in vitro, its mechanism of action mediated by cyclic AMP and/or other intracellular signalling pathways. Exenatide increases, on a glucose-dependent basis, the secretion of insulin from pancreatic beta cells. Read about Exenatide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BJ01	Exenatide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BJ Glucagon-like peptide-1 (GLP-1) analogues
Discover more medicines within A10BJ01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10888C
Country: CA	Health Products and Food Branch	Identifier(s): 02448610
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1152-MEE-0715
Country: EE	Ravimiamet	Identifier(s): 1533787, 1533798, 1778902, 1802304
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 111696003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 088891, 514501
Country: FR	Base de données publique des médicaments	Identifier(s): 66105532
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 284261, 375913, 380606
Country: HK	Department of Health Drug Office	Identifier(s): 64579, 66530
Country: IE	Health Products Regulatory Authority	Identifier(s): 13106, 54347
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7354
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1061235, 1061236, 1076648, 1076649, 1086385, 1088387
Country: NL	Z-Index G-Standaard	Identifier(s): 16137841
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 125636
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 17293
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100252744
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64922001
Country: SG	Health Sciences Authority	Identifier(s): 15095P
Country: US	FDA, National Drug Code	Identifier(s): 0310-6530, 0310-6540